High impact company profile available at BioMarket

Dendreon Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, laboratory equipme

Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by different mechani

Varian Medical Systems (Varian) is one of the leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company is also a supplier of tub

Halozyme Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Cytori Therapeutics (previously MacroPore Biosurgery), based in San Diego, California, is one of the leading companies in the development and commercialization of regenerative medicine products.

High impact company profile available at BioMarket

High impact company profile available at BioMarket

Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio.

High impact company profile available at BioMarket

High impact company profile available at BioMarket

Natus Medical Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology

High impact company profile available at BioMarket

ARYx Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

SenoRx Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

High impact company profile available at BioMarket

BTG plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

The "Nordic Life Science Industry Guide 2008" is a unique CD-ROM product that contains a searchable directory of 1,500 life science companies in Scandinavia (Denmark, Norway, Finland and Sweden).

Vernalis plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Javelin Pharmaceuticals is a late development stage specialty pharmaceutical company that discovers, develops and commercializes drugs and improved formulations of existing drugs that target pain management market.

High impact company profile available at BioMarket

Flamel Technologies SA: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Introgen Therapeutics (Introgen) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer. The company has been successful in developing a strong portfolio of

Somaxon Pharmaceuticals (Somaxon) is a development stage pharmaceutical company engaged in in-licensing and developing proprietary product candidates for the treatment of psychiatry and neurology disorders.

Boston Scientific is one of the leading companies in less-invasive medical devices market offering more than 15,000 products in over 45 countries across the world under the four core business groups: cardiovascular, endosurgery, neuromodulation and car

Illumina is one of the leading companies in genome and genotyping market. The company’s proprietary technology enables conversion of raw sequence data from the human genome into medically relevant information. The January 2007 acquisition of Sole